What is NDC 63323-778?

63323-778 is the product NDC for Methocarbamol, Methocarbamol 100 mg/mL injection, solution, listed with the FDA by Fresenius Kabi USA, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Fresenius Kabi USA, LLC, NDC labeler code 63323. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Methocarbamol?

197 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Methocarbamol NDC 63323-778 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)63323-778Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63323-0778Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63323-778-10	63323077810	25 VIAL in 1 CARTON (63323-778-10) / 10 mL in 1 VIAL (63323-778-21)Marketed from Apr 17, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Methocarbamol
Generic name (nonproprietary): methocarbamol
Active ingredients: Methocarbamol — 100 mg/mL
Dosage form: Injection, Solution
Route: Intramuscular, Intravenous
Labeler: Fresenius Kabi USA, LLCNDC labeler code 63323
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 209331
Marketing start: Apr 17, 2018
Listing expires: Dec 31, 2026
Other FDA classes: Centrally-mediated Muscle Relaxation (Physiologic effect)
Identifiers: Product ID 63323-778_ee1af98a-62a0-4831-b3c1-45607737b32fSPL ID ee1af98a-62a0-4831-b3c1-45607737b32fSPL set ID bdf17640-221c-4c80-b48c-101daaece1d6RxCUI 238175UNII 125OD7737XUPC 0363323778217
Pharmacologic class: Muscle Relaxant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N463323077810 followed by a unit qualifier and the quantity

Package 63323-0778-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 22, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE: The injection form of methocarbamol is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. The mode of action of this drug has not been clearly identified, but may be related to its sedative properties. Methocarbamol does not directly relax tense skeletal muscles in man.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 63323-778

What is NDC 63323-778?: 63323-778 is the product NDC for Methocarbamol, Methocarbamol 100 mg/mL injection, solution, listed with the FDA by Fresenius Kabi USA, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Methocarbamol.
What is the active ingredient?: Methocarbamol.
Who is the labeler?: Fresenius Kabi USA, LLC, NDC labeler code 63323. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Methocarbamol?: 197 other product NDCs are listed under this name. See all Methocarbamol NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Methocarbamol NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Methocarbamol	Methocarbamol 500 mg/1	Tablet, Film coatedOral	St. Mary's Medical Park Pharmacy	60760-874	60760-0874-90
Methocarbamolmethocarbamol tablets	Methocarbamol 750 mg/1	Tablet, CoatedOral	Coupler LLC	67046-0340	67046-0340-03
Methocarbamol	Methocarbamol 500 mg/1	TabletOral	Coupler LLC	67046-1177	67046-1177-03
Methocarbamol	Methocarbamol 500 mg/1	Tablet, Film coatedOral	Medcore LLC	82461-722	82461-0722-90
Methocarbamol	Methocarbamol 750 mg/1	Tablet, Film coatedOral	Medcore LLC	82461-723	82461-0723-90
Methocarbamolmethocarbamol tablets	Methocarbamol 500 mg/1	Tablet, CoatedOral	Unit Dose Solutions, Inc.	87441-086	87441-0086-01
Methocarbamol	Methocarbamol 750 mg/1	Tablet, Film coatedOral	St. Mary's Medical Park Pharmacy	60760-875	60760-0875-2860760-0875-4060760-0875-90
Methocarbamol	Methocarbamol 500 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-057	87441-0057-01
Methocarbamolmethocarbamol tablets	Methocarbamol 500 mg/1	Tablet, CoatedOral	Coupler LLC	67046-0538	67046-0538-03
Methocarbamol	Methocarbamol 100 mg/mL	InjectionIntramuscular, Intravenous, Intravenous	JVET PHARMACEUTICALS LLC	86211-114	86211-0114-10

All 198 Methocarbamol NDCs